Literature DB >> 30116046

Targeting the NLRP3 inflammasome in inflammatory diseases.

Matthew S J Mangan, Edward J Olhava, William R Roush, H Martin Seidel, Gary D Glick, Eicke Latz.   

Abstract

This corrects the article DOI: 10.1038/nrd.2018.97.

Entities:  

Year:  2018        PMID： 30116046     DOI： 10.1038/nrd.2018.149

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  1 in total

Review 1.  Targeting the NLRP3 inflammasome in inflammatory diseases.

Authors:  Matthew S J Mangan; Edward J Olhava; William R Roush; H Martin Seidel; Gary D Glick; Eicke Latz
Journal:  Nat Rev Drug Discov       Date:  2018-07-20       Impact factor: 84.694
  1 in total
  89 in total

Review 1.  The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes.

Authors:  David A Sallman; Alan List
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

2.  Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation.

Authors:  Qiulan Lv; Daxing Xu; Jinfeng Ma; Yan Wang; Xiaomin Yang; Peng Zhao; Liang Ma; Zhiyuan Li; Wan Yang; Xiu Liu; Guanpin Yang; Shichao Xing
Journal:  Inflamm Res       Date:  2020-10-19       Impact factor: 4.575

3.  Genetic landscape and autoimmunity of monocytes in developing Vogt-Koyanagi-Harada disease.

Authors:  Youjin Hu; Yixin Hu; Yuhua Xiao; Feng Wen; Shaochong Zhang; Dan Liang; Lishi Su; Yang Deng; Jiawen Luo; Jingsong Ou; Mingzhi Lu; Yanhua Hong; Wei Chi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-28       Impact factor: 11.205

4.  Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome†.

Authors:  Jonathan Faro; Roberto Romero; George Schwenkel; Valeria Garcia-Flores; Marcia Arenas-Hernandez; Yaozhu Leng; Yi Xu; Derek Miller; Sonia S Hassan; Nardhy Gomez-Lopez
Journal:  Biol Reprod       Date:  2019-05-01       Impact factor: 4.285

5.  Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis.

Authors:  Liming Mao; Atsushi Kitani; Eitaro Hiejima; Kim Montgomery-Recht; Wenchang Zhou; Ivan Fuss; Adrian Wiestner; Warren Strober
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 6.  Caspases in Cell Death, Inflammation, and Disease.

Authors:  Nina Van Opdenbosch; Mohamed Lamkanfi
Journal:  Immunity       Date:  2019-06-18       Impact factor: 31.745

Review 7.  Recent Insights on Inflammasomes, Gasdermin Pores, and Pyroptosis.

Authors:  Nathalia M de Vasconcelos; Mohamed Lamkanfi
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-05-01       Impact factor: 10.005

8.  NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling.

Authors:  Xabier Unamuno; Javier Gómez-Ambrosi; Beatriz Ramírez; Amaia Rodríguez; Sara Becerril; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Gema Frühbeck; Victoria Catalán
Journal:  Cell Mol Immunol       Date:  2019-09-24       Impact factor: 11.530

9.  Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1β Production.

Authors:  Marwa Qadri; Sandy ElSayed; Khaled A Elsaid
Journal:  J Pharmacol Exp Ther       Date:  2020-11-25       Impact factor: 4.030

10.  Selective inhibition of the K+ efflux sensitive NLRP3 pathway by Cl- channel modulation.

Authors:  Tessa Swanton; James A Beswick; Halah Hammadi; Lucy Morris; Daniel Williams; Stephane de Cesco; Lina El-Sharkawy; Shi Yu; Jack Green; John B Davis; Catherine B Lawrence; David Brough; Sally Freeman
Journal:  Chem Sci       Date:  2020-10-12       Impact factor: 9.825
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.